Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 9/1/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Jamil Aarbiou?

Jamil Aarbiou

Team Leader

BioFocus plc

HQ Phone:  +44 1799 533500

Email: j***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

BioFocus plc

Chesterford Research Park

Saffron Walden, Essex,CB10 1XL

United Kingdom

Company Description

BioFocus DPI aims to expand its partners’ drug pipelines by accelerating the gene-to-candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse ... more

Find other employees at this company (10)

Background Information

Employment History

Team Leader

Galapagos NV


Group Leader Discovery

Charles River Laboratories International Inc


Web References(1 Total References)


www.genengnews.com

"We use cells derived from tissue, blood, or differentiated stem cells to provide the most relevant biology for developing high-throughput assays that aid drug discovery," says Jamil Aarbiou, Ph.D., a team leader at the BioFocus unit that Charles River currently maintains in Leiden.
In addition to the human primary cell-based assays, the company has developed more than 300 drug discovery assays and performed more than 100 screening campaigns comprising more than 30 million test wells. "We also develop and perform client-specific assays," notes Dr. Aarbiou. "These may include RNAi-based screens, tests of drug candidates on patient-derived cell models, and target-based screens." Two of the challenges faced with phenotypic screening and testing are variability among donors and the need for low passage number of patient-derived cells. "To overcome this variability, we assess similar cell models from a number of donors," explains Dr. Aarbiou.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory